Trial Profile
Randomized Controlled Exploratory Study in Healthy Subjects with Dapagliflozin on Energy Intake and Appetite
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Chronic heart failure; Kidney disorders; Obesity; Renal failure; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 May 2018 New trial record